Cargando…
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
The androgen receptor is a transcription factor and validated therapeutic target for prostate cancer. Androgen deprivation therapy remains the gold standard treatment, but it is not curative, and eventually the disease will return as lethal castration‐resistant prostate cancer. There have been impro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680212/ https://www.ncbi.nlm.nih.gov/pubmed/27302572 http://dx.doi.org/10.1111/iju.13137 |